| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/05/2011 | CA2360326C Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/31/2011 | WO2011038394A2 Silk fibroin-decorin scaffolds |
| 03/31/2011 | WO2011038116A2 Composition comprising pomegranate polyphenols for improving bone health |
| 03/31/2011 | WO2011038097A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011038086A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011038064A2 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 03/31/2011 | WO2011037795A1 Compounds which selectively modulate the cb2 receptor |
| 03/31/2011 | WO2011037467A1 Atazanavir for treating inflammatory diseases |
| 03/31/2011 | WO2011037223A1 Agent for reducing visceral fat weight |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036357A2 Stable, liquid, ready-to-use ketoprofen formulation |
| 03/31/2011 | WO2011036303A1 New aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the met family |
| 03/31/2011 | WO2011036047A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases |
| 03/31/2011 | WO2011035855A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 03/31/2011 | WO2011035829A1 Pharmaceutical compositions for treating dysregulated inflammatory diseases |
| 03/31/2011 | WO2011035734A1 Relinqing extract, preparative method and use thereof |
| 03/31/2011 | WO2011035534A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | WO2010147440A3 Health food or pharmaceutical composition comprising chestnut shell extract |
| 03/31/2011 | WO2010142663A8 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof |
| 03/31/2011 | WO2009129246A3 Compositions and methods for preparing and using same |
| 03/31/2011 | US20110077306 Stat3 inhibiting compositions and methods |
| 03/31/2011 | US20110077299 Inhibitors of alpha4 mediated cell adhesion |
| 03/31/2011 | US20110077297 Compositions and methods for treatment of inflammation and hyperkeratotic lesions |
| 03/31/2011 | US20110077289 Method of treating pneumoconiosis with oligodeoxynucleotides |
| 03/31/2011 | US20110077282 Novel compounds from antrodia camphorata |
| 03/31/2011 | US20110077270 Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| 03/31/2011 | US20110077269 Derivatives for modulation of ion channels |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077264 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 03/31/2011 | US20110077254 Compounds |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077246 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 03/31/2011 | US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 03/31/2011 | US20110077239 Glycine receptor agonists for the treatment of phantom phenomena |
| 03/31/2011 | US20110077237 Kinase inhibitors |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/31/2011 | US20110077231 Compounds |
| 03/31/2011 | US20110077224 Linoleic phospholipids and uses thereof for inhibiting inflammatory and neurodegenerative processes |
| 03/31/2011 | US20110077211 Methods and compositions for treating luminal inflammatory disease |
| 03/31/2011 | US20110077207 Method for treating inflammation |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077193 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for the Treatment of Infection and Topical Condition in Mammals |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076336 Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| 03/31/2011 | US20110076331 Use of Deuterium Oxide as an Elastase Inhibitor |
| 03/31/2011 | US20110076327 Herbal Pain Killer Compositions |
| 03/31/2011 | US20110076322 Amphoteric liposomes |
| 03/31/2011 | US20110076321 Self-adhesive polymer matrix containing sea algae extract |
| 03/31/2011 | US20110076311 Ceramide dispersion |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076279 Fully human anti-vegf antibodies and methods of using |
| 03/31/2011 | US20110076278 Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders |
| 03/31/2011 | US20110076267 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/31/2011 | US20110076250 Biodegradable Absorbents and Methods of Preparation |
| 03/31/2011 | US20110076249 Immunotherapy for immune suppressed patients |
| 03/31/2011 | US20110073518 Generally Linear Effervescent Oral Fentanyl Dosage Form and Methods of Administering |
| 03/31/2011 | CA2775475A1 Pyridinylimidazolone derivatives for inhibition of pi3 kinases |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774731A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/31/2011 | CA2760180A1 Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2301550A1 Tetracycline compounds having target therapeutic activities |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301525A1 Topical ibuprofen formulation |
| 03/30/2011 | EP2301494A1 Sustained analgesia achieved with buprenorphine |
| 03/30/2011 | EP2301493A1 Sustained analgesia achieved with buprenorphine |
| 03/30/2011 | EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/30/2011 | EP2300474A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists |
| 03/30/2011 | EP2300466A1 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
| 03/30/2011 | EP2300443A1 Triazole derivatives useful for the treatment of diseases |
| 03/30/2011 | EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists |
| 03/30/2011 | EP2300437A1 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 03/30/2011 | EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/30/2011 | EP2300428A1 Aminopyridine derivatives |
| 03/30/2011 | EP2300043A1 Analgesic effects of peptide toxin apetx2 |
| 03/30/2011 | EP2300030A2 Rice bran extracts and methods of use thereof |
| 03/30/2011 | EP2300029A2 Rice bran extracts for inflammation and methods of use thereof |
| 03/30/2011 | EP2125736B1 Substituted acetophenones useful as pde4 inhibitors |
| 03/30/2011 | EP1940835B1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 03/30/2011 | EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |